title: Compliance of an institution-specific alcohol withdrawal protocol with evidence-based practice guidelines.
authors.affiliation: Department of Pharmacy Practice, School of Pharmacy, University of Kansas Medical Center, Kansas City, Kansas 66160, USA. kmoeller@kumc.edu
authors.forename: Karen E
authors.initials: KE
authors.lastname: Moeller
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Barnes
authors.forename: Karen M
authors.initials: KM
authors.lastname: Stanley
authors.forename: Cathy L
authors.initials: CL
authors.lastname: Worrall
authors.forename: Shayna L
authors.initials: SL
authors.lastname: Lunsford
authors.forename: Kit N
authors.initials: KN
authors.lastname: Simpson
authors.forename: Justin G
authors.initials: JG
authors.lastname: Miller
authors.forename: Anne P
authors.initials: AP
authors.lastname: Spencer
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D000431:Ethanol / Q000009:adverse effects*; D019317:Evidence-Based Medicine; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy* / Q000523:psychology
chemical_list: D000316:Adrenergic alpha-Agonists; D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D000431:Ethanol; D006220:Haloperidol; D003000:Clonidine; D008140:Lorazepam